Intriguingly, we found here that Hpcal1-deficient tumors displayed molecular signature of lipid metabolic reprogramming and triggered numerous genes implicated in de novo fatty acid and cholesterol biosynthesis, an emerging hallmark of cancer metabolism occurs in aggressive tumors and correlates with therapeutic resistance 8, 12. This evidence concerns the gene HPCAL1 and cancer.